211 related articles for article (PubMed ID: 31828126)
1. Myoferlin, a Membrane Protein with Emerging Oncogenic Roles.
Dong Y; Kang H; Liu H; Wang J; Guo Q; Song C; Sun Y; Zhang Y; Zhang H; Zhang Z; Guan H; Fang Z; Li F
Biomed Res Int; 2019; 2019():7365913. PubMed ID: 31828126
[TBL] [Abstract][Full Text] [Related]
2. An Emerging Therapeutic Approach by Targeting Myoferlin (MYOF) for Malignant Tumors.
Gu H; Peng Y; Chen Y
Curr Top Med Chem; 2020; 20(17):1509-1515. PubMed ID: 32552653
[TBL] [Abstract][Full Text] [Related]
3. Myoferlin depletion in breast cancer cells promotes mesenchymal to epithelial shape change and stalls invasion.
Li R; Ackerman WE; Mihai C; Volakis LI; Ghadiali S; Kniss DA
PLoS One; 2012; 7(6):e39766. PubMed ID: 22761893
[TBL] [Abstract][Full Text] [Related]
4. High expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-status.
Kumar B; Brown NV; Swanson BJ; Schmitt AC; Old M; Ozer E; Agrawal A; Schuller DE; Teknos TN; Kumar P
Oncotarget; 2016 Apr; 7(14):18665-77. PubMed ID: 26919244
[TBL] [Abstract][Full Text] [Related]
5. Loss of myoferlin redirects breast cancer cell motility towards collective migration.
Volakis LI; Li R; Ackerman WE; Mihai C; Bechel M; Summerfield TL; Ahn CS; Powell HM; Zielinski R; Rosol TJ; Ghadiali SN; Kniss DA
PLoS One; 2014; 9(2):e86110. PubMed ID: 24586247
[TBL] [Abstract][Full Text] [Related]
6. Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition.
Zhang W; Zhou P; Meng A; Zhang R; Zhou Y
J Cell Mol Med; 2018 Mar; 22(3):1743-1754. PubMed ID: 29164766
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic modeling of the effects of myoferlin on tumor cell invasion.
Eisenberg MC; Kim Y; Li R; Ackerman WE; Kniss DA; Friedman A
Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20078-83. PubMed ID: 22135466
[TBL] [Abstract][Full Text] [Related]
8. Loss of dysferlin or myoferlin results in differential defects in excitation-contraction coupling in mouse skeletal muscle.
Barefield DY; Sell JJ; Tahtah I; Kearns SD; McNally EM; Demonbreun AR
Sci Rep; 2021 Aug; 11(1):15865. PubMed ID: 34354129
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of Myoferlin Suppresses Migration and Invasion in Clear-Cell Renal-Cell Carcinoma.
Cox A; Zhao C; Tolkach Y; Nettersheim D; Schmidt D; Kristiansen G; Mueller SC; Ritter M; Hauser S; Ellinger J
Anticancer Res; 2020 Jun; 40(6):3119-3128. PubMed ID: 32487606
[TBL] [Abstract][Full Text] [Related]
10. A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer.
Zhang T; Li J; He Y; Yang F; Hao Y; Jin W; Wu J; Sun Z; Li Y; Chen Y; Yi Z; Liu M
Nat Commun; 2018 Sep; 9(1):3726. PubMed ID: 30213946
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a Highly Potent and Selective MYOF Inhibitor with Improved Water Solubility for the Treatment of Gastric Cancer.
Gu H; Zhang T; Guan T; Wu M; Li S; Li Y; Guo M; Zhang L; Peng Y; Mi D; Liu M; Yi Z; Chen Y
J Med Chem; 2023 Dec; 66(24):16917-16938. PubMed ID: 38054798
[TBL] [Abstract][Full Text] [Related]
12. Myoferlin Regulates Wnt/β-Catenin Signaling-Mediated Skeletal Muscle Development by Stabilizing Dishevelled-2 Against Autophagy.
Han S; Cui C; He H; Shen X; Chen Y; Wang Y; Li D; Zhu Q; Yin H
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31623157
[TBL] [Abstract][Full Text] [Related]
13. Myoferlin, a multifunctional protein in normal cells, has novel and key roles in various cancers.
Zhu W; Zhou B; Zhao C; Ba Z; Xu H; Yan X; Liu W; Zhu B; Wang L; Ren C
J Cell Mol Med; 2019 Nov; 23(11):7180-7189. PubMed ID: 31475450
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of Myoferlin in Human Pancreatic Cancer via Bioinformatics.
Pi R; Chen Y; Du Y; Dong S
Biomed Res Int; 2021; 2021():2602322. PubMed ID: 34957301
[TBL] [Abstract][Full Text] [Related]
15. Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance.
Harada K; Sakamoto N; Ukai S; Yamamoto Y; Pham QT; Taniyama D; Honma R; Maruyama R; Takashima T; Ota H; Takemoto Y; Tanabe K; Ohdan H; Yasui W
Gastric Cancer; 2021 Nov; 24(6):1264-1277. PubMed ID: 34272617
[TBL] [Abstract][Full Text] [Related]
16. Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin.
Li Y; He Y; Shao T; Pei H; Guo W; Mi D; Krimm I; Zhang Y; Wang P; Wang X; Liu M; Yi Z; Chen Y
J Med Chem; 2019 May; 62(10):4949-4966. PubMed ID: 31026162
[TBL] [Abstract][Full Text] [Related]
17. A potent and selective small molecule inhibitor of myoferlin attenuates colorectal cancer progression.
He Y; Kan W; Li Y; Hao Y; Huang A; Gu H; Wang M; Wang Q; Chen J; Sun Z; Liu M; Chen Y; Yi Z
Clin Transl Med; 2021 Feb; 11(2):e289. PubMed ID: 33634965
[TBL] [Abstract][Full Text] [Related]
18. Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer.
Blomme A; Costanza B; de Tullio P; Thiry M; Van Simaeys G; Boutry S; Doumont G; Di Valentin E; Hirano T; Yokobori T; Gofflot S; Peulen O; Bellahcène A; Sherer F; Le Goff C; Cavalier E; Mouithys-Mickalad A; Jouret F; Cusumano PG; Lifrange E; Muller RN; Goldman S; Delvenne P; De Pauw E; Nishiyama M; Castronovo V; Turtoi A
Oncogene; 2017 Apr; 36(15):2116-2130. PubMed ID: 27775075
[TBL] [Abstract][Full Text] [Related]
19. Myoferlin is a key regulator of EGFR activity in breast cancer.
Turtoi A; Blomme A; Bellahcène A; Gilles C; Hennequière V; Peixoto P; Bianchi E; Noel A; De Pauw E; Lifrange E; Delvenne P; Castronovo V
Cancer Res; 2013 Sep; 73(17):5438-48. PubMed ID: 23864327
[TBL] [Abstract][Full Text] [Related]
20. Ferlin Overview: From Membrane to Cancer Biology.
Peulen O; Rademaker G; Anania S; Turtoi A; Bellahcène A; Castronovo V
Cells; 2019 Aug; 8(9):. PubMed ID: 31443490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
